Healthcare
Vantis Vascular – SUCCESS PAGE – December 11, 2025
Vantis Vascular is developing breakthrough tools to deliver game-changing outcomes in advanced vascular intervention
Vantis Vascular is developing breakthrough tools to deliver game-changing outcomes in advanced vascular intervention
AvenCell Therapeutics is pioneering the next generation of cancer treatment with powerful, persistent, and switchable allogeneic CAR-T therapies
AvenCell Therapeutics is pioneering the next generation of cancer treatment with powerful, persistent, and switchable allogeneic CAR-T therapies
Regenxbio [NASDAQ: RGNX] has three assets in pivotal trials with the potential to become standard of care in markets worth a total of $26B.
Vantis Vascular is developing breakthrough tools to deliver game-changing outcomes in advanced vascular intervention
Regenxbio [NASDAQ: RGNX] has three assets in pivotal trials with the potential to become standard of care in markets worth a total of $26B.
Duo Oncology is a next-generation biotech company creating a nanomedicine platform that replaces chemotherapy for hard-to-treat cancers
Duo Oncology is a next-generation biotech company creating a nanomedicine platform that replaces chemotherapy for hard-to-treat cancers
Xgene is using its proprietary conjugate platform technology to provide highly effective non-opioid relief for acute and chronic pain
Xgene is using its proprietary conjugate platform technology to provide highly effective non-opioid relief for acute and chronic pain
BrainScope is working with the Alzheimer’s Drug Discovery Foundation to to transform how Alzheimer’s is diagnosed and treated
A global, vertically integrated, biopharmaceutical company on a mission to transform the treatment of cancer